Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Switzerland Daily Monitor.
Press releases published on August 13, 2025

Pitcher Recognized in Five Gartner® Hype Cycle Reports ™ for Summer 2025
DENVER, CO, UNITED STATES, August 13, 2025 /EINPresswire.com/ -- Gartner has recognized Pitcher’s Sales Enablement 2.0 platform in five Gartner Hype Cycles published in July 2025. “Gartner Hype Cycles provide a graphic representation of the maturity …

Global Travel Technology Market Valued at $9.4 Billion in 2022, Set to Hit $21 Billion by 2032
WILMINGTON, NEW CASTLE, DE, UNITED STATES, August 13, 2025 /EINPresswire.com/ -- Allied Market Research published a report, titled, "Travel Technology Market by Component (Platform and Service), Application (Travel Industry, Tourism Industry, and …

YouBallin Launches to Give Power Back to Creators
YouBallin is a Web3 talent platform where discovery is driven by people, not algorithms, letting fans decide who rises LUGANO, Switzerland, Aug. 13, 2025 (GLOBE NEWSWIRE) -- YouBallin is the first Web3 talent platform where communities, not algorithms, …

SEALCOIN and Thomson Metavisio Bring Decentralized Computing to Consumer Laptops
SEALCOIN and Thomson Metavisio Bring Decentralized Computing to Consumer Laptops SEALCOIN enables the computing shift from centralized data centers to a user-powered, secure, and distributed computing network Geneva, Switzerland …

The Foundation for New Creative Economies (FNCE) Welcomes Bruce Pon as a Board Member
Zug, Switzerland, Aug. 13, 2025 (GLOBE NEWSWIRE) -- The Foundation for New Creative Economies (FNCΞ), the independent organization supporting growth and innovation within the LUKSO ecosystem, is proud to announce that Bruce Pon has joined as a board member …

Santhera schließt Vereinbarung mit GEN über den Vertrieb von AGAMREE® (Vamorolon) in der Türkei
Pratteln, Schweiz, 13. August 2025 – Santhera Pharmaceuticals (SIX: SANN) gibt die Unterzeichnung einer exklusiven Vereinbarung mit Gen İlaç ve Sağlık Ürünleri San. ve Tic. A.Ş. (GEN) über den Vertrieb und die Vermarktung von AGAMREE® (Vamorolon) in der …

Santhera Secures Agreement with GEN for the Distribution of AGAMREE® (Vamorolone) in Türkiye
Pratteln, Switzerland, 13 August, 2025 – Santhera Pharmaceuticals (SIX: SANN) announces the signing of an exclusive agreement with Gen İlaç ve Sağlık Ürünleri San. ve Tic. A.Ş. (GEN) for the distribution and promotion of AGAMREE® (vamorolone) in Türkiye …